Skip to main content
. 2023 May 30;24(11):9486. doi: 10.3390/ijms24119486

Table 2.

Differentially expressed genes involved in gabaergic, cholinergic or dopaminergic synapsis.

Gene CTRL Δ8-THC log2 Fold Change q-Value Synapsis
GABRA3 551.40 616.31 0.16 2.03 × 10−2 Gabaergic
GABRG3 50.57 98.84 0.97 1.12 × 10−6 Gabaergic
GABRR2 30.10 17.44 −0.79 2.27 × 10−2 Gabaergic
CHRNA3 3521.51 3364.80 −0.07 2.01 × 10−2 Cholinergic
CHRNA6 15.65 1.66 −3.24 1.60 × 10−4 Cholinergic
CHRNA7 2073.17 1844.79 −0.17 2.26 × 10−6 Cholinergic
CHRNB2 9219.72 8367.57 −0.14 5.31 × 10−18 Cholinergic
PRKACB 3247.01 3042.53 −0.09 1.17 × 10−3 Cholinergic
MAPK1 1856.47 1716.04 −0.11 3.28 × 10−3 Cholinergic
CREB3L3 13.24 4.98 −1.41 1.67 × 10−2 Cholinergic
CREB3L4 1438.70 1281.63 −0.17 1.24 × 10−4 Cholinergic
CREB5 2677.55 2544.16 −0.07 2.34 × 10−2 Cholinergic
SLC18A3 280.52 213.47 −0.39 1.11 × 10−4 Cholinergic
DRD4 108.35 54.82 −0.98 3.20 × 10−8 Dopaminergic
CALY 7.22 1.66 −2.12 2.62 × 10−2 Dopaminergic
DDC 13,066.29 12,497.37 −0.06 4.46 × 10−6 Dopaminergic

For each DEG, the difference in the level of expression computed by log2(∆8-THC/CTRL) results in the log2 fold change. The post hoc correction of the p-value is highlighted in q-Value column. All values were rounded to the second decimal digit.